CompaniesAvilex Pharma
Avilex Pharma logo

Avilex Pharma

active
Copenhagen, Denmark
Founded 2012
Website
About

Peptide for ischemic stroke

Areas of Focus

Categories

Gene Therapy, RNA & Peptide Therapy
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

46

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
Today
NCT04689035
Hover over trial bars to see details

Recent Trials

NCT04689035Lead Sponsor
A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144
PHASE1Completed
46 participants
Started: Sep 27, 2020 · Completed: Jul 1, 2023
Locations (1)
Headquarters
Copenhagen, Denmark
Map

Loading map...